• S2 Ep12: From Infection to Innovation: The Turn Therapeutics Story

  • Jun 4 2024
  • Duración: 19 m
  • Podcast

S2 Ep12: From Infection to Innovation: The Turn Therapeutics Story  Por  arte de portada

S2 Ep12: From Infection to Innovation: The Turn Therapeutics Story

  • Resumen

  • Bradley Burnam, the founder and CEO of Turn Therapeutics, discusses his journey in the pharmaceutical landscape: from his battle with an aggressive antimicrobial resistant infection to the beginnings of Turn, and to the current state of Hexagen technology and its potential in eczema, onychomycosis, and more.
    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre S2 Ep12: From Infection to Innovation: The Turn Therapeutics Story

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.